Related Experiment Video
Updated: Dec 15, 2025
10:01
Directed Assembly of Elastin-like Proteins into defined Supramolecular Structures and Cargo Encapsulation In Vitro
Published on: April 8, 2020
6.2K
Molecular assembly of biomimetic microcapsules
Junbai Li1, Helmuth Möhwald2, Zhihua An1
1International Joint Lab, Key Lab of Colloid and Interface Science, the Center for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Zhong Guan Cun, Beijing 100080, China.
Soft Matter
|July 11, 2020
Summary
Researchers developed novel biomimetic microcapsules using human serum albumin (HSA) and dimyristoylphosphatidic acid (DMPA). These biocompatible lipid-protein structures show promise for advanced drug delivery systems.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Microcapsules are essential for drug delivery and biomimetic research.
- Protein-lipid interactions are key to developing advanced biomaterials.
Purpose of the Study:
- To review the fabrication of novel microcapsules using human serum albumin (HSA) and dimyristoylphosphatidic acid (DMPA).
- To explore the potential of these biomimetic microcapsules for sustained drug release applications.
Main Methods:
- Fabrication via stepwise adsorption of HSA and DMPA onto fluid droplet surfaces or charged colloids.
- Subsequent dissolution of the core to form hollow lipid-protein microcapsules.
- Characterization of the self-assembled lipid bilayer structure on the protein surface.
Main Results:
- Successfully fabricated HSA/DMPA microcapsules with a biomimetic membrane model.
- Demonstrated good biocompatibility of the DMPA/HSA microcapsules.
- Identified potential for incorporating recognition units into the lipid bilayers.
Conclusions:
- The described lipid-protein microcapsules offer a promising platform for biomimetic research.
- These microcapsules exhibit significant potential for developing effective sustained drug release systems.
